Inhibition of the Staphylococcus aureus sortase transpeptidase SrtA by phosphinic peptidomimetics

Ryan G Kruger1, Salim Barkallah, Brenda A Frankel

  • 1Department of Biochemistry and Biophysics and the Johnson Research Foundation, The University of Pennsylvania School of Medicine, 905A Stellar-Chance Building, 422 Curie Blvd., Philadelphia, PA 19104-6059, USA.

Insights

Researchers developed a novel phosphinic peptidomimetic inhibitor targeting the SrtA enzyme in Staphylococcus aureus. This inhibitor blocks surface protein anchoring, offering a promising antivirulence strategy against Gram-positive bacterial infections.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Gram-positive bacteria use surface proteins like MSCRAMMs for infection.
  • These proteins anchor to peptidoglycan via the LPXTG motif and sortase enzymes.
  • Staphylococcus aureus SrtA is a key virulence factor and antivirulence target.

Purpose of the Study:

  • To design and synthesize a nonhydrolyzable inhibitor of the SrtA enzyme.
  • To investigate the kinetic properties of this novel inhibitor.
  • To explore a new antivirulence strategy against Staphylococcus aureus.

Main Methods:

  • Chemical synthesis of a phosphinic peptidomimetic.
  • Kinetic characterization of the SrtA inhibitor.
  • Utilizing the LPXTG substrate sequence for inhibitor design.

Main Results:

  • Successful chemical synthesis of a nonhydrolyzable SrtA inhibitor.
  • Characterization of the inhibitor's kinetic parameters.
  • Demonstration of a peptidomimetic approach for sortase inhibition.

Conclusions:

  • The developed phosphinic peptidomimetic effectively inhibits SrtA.
  • This inhibitor represents a potential therapeutic agent against Staphylococcus aureus infections.
  • Targeting sortase-mediated anchoring offers a viable antivirulence strategy.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...